Search research articles
Contact Us
Filters
Showing results (91-100 of 276) with videos related to
Page
of 28
Sort By:
Connecticut Medicine
|
April 1, 1997
Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationale
R C Owens, P G Ambrose, R Quintiliani
Antimicrobial Agents and Chemotherapy
|
March 1, 1978
Aminoglycoside antibiotics moderately impair granulocyte function
M M Seklecki, R Quintiliani, E G Maderazo
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1988
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa
J G Zhi, C H Nightingale, R Quintiliani
Connecticut Medicine
|
October 1, 1998
Trovafloxacin: fourth generation fluoroquinolone
J McNabb, D Nicolau, R Quintiliani, et al.
The Journal of Infectious Diseases
|
April 1, 1986
Restriction policies for therapy with combination antibiotics
R Quintiliani, J J Klimek, C H Nightingale
The Journal of Antimicrobial Chemotherapy
|
January 1, 1985
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model
J J Mordenti, R Quintiliani, C H Nightingale
Clinical Pharmacokinetics
|
October 1, 1989
Clinical pharmacokinetics of ceftriaxone
J H Yuk, C H Nightingale, R Quintiliani
Journal of Pharmaceutical Sciences
|
November 1, 1988
Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice
J G Zhi, C H Nightingale, R Quintiliani
The Journal of Infectious Diseases
|
December 1, 1985
An improved method to determine interstitial fluid pharmacokinetics
W C Shyu, R Quintiliani, C H Nightingale
The Journal of Antimicrobial Chemotherapy
|
February 1, 1988
The pharmacokinetics of metronidazole and its metabolites in critically ill patients
K I Plaisance, R Quintiliani, C H Nightingale
Page
of 28
Search research articles
Search
Showing results (91-100 of 276) with videos related to
Sort By:
Page
of 28
Connecticut Medicine
|
April 1, 1997
Ceftazidime to cefepime formulary switch: pharmacodynamic and pharmacoeconomic rationale
R C Owens, P G Ambrose, R Quintiliani
Antimicrobial Agents and Chemotherapy
|
March 1, 1978
Aminoglycoside antibiotics moderately impair granulocyte function
M M Seklecki, R Quintiliani, E G Maderazo
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1988
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa
J G Zhi, C H Nightingale, R Quintiliani
Connecticut Medicine
|
October 1, 1998
Trovafloxacin: fourth generation fluoroquinolone
J McNabb, D Nicolau, R Quintiliani, et al.
The Journal of Infectious Diseases
|
April 1, 1986
Restriction policies for therapy with combination antibiotics
R Quintiliani, J J Klimek, C H Nightingale
The Journal of Antimicrobial Chemotherapy
|
January 1, 1985
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model
J J Mordenti, R Quintiliani, C H Nightingale
Clinical Pharmacokinetics
|
October 1, 1989
Clinical pharmacokinetics of ceftriaxone
J H Yuk, C H Nightingale, R Quintiliani
Journal of Pharmaceutical Sciences
|
November 1, 1988
Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice
J G Zhi, C H Nightingale, R Quintiliani
The Journal of Infectious Diseases
|
December 1, 1985
An improved method to determine interstitial fluid pharmacokinetics
W C Shyu, R Quintiliani, C H Nightingale
The Journal of Antimicrobial Chemotherapy
|
February 1, 1988
The pharmacokinetics of metronidazole and its metabolites in critically ill patients
K I Plaisance, R Quintiliani, C H Nightingale
Page
of 28